Consistent with previous findings, KIBRA levels were significantly reduced in individuals with moderate-to-severe dementia (CDR 2–3) compared with those with none-to-mild (CDR 0–1) clinical impairment (Figure 1D). The gene discussed is WWC1; the disease is dementia.